Skip to main content

Table 1 Clinicopathologic characteristics of BC samples, before NAC, for all patients included (n = 196a)

From: CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

CharacteristicsCategoriesn%
TNM - TT121.0
T2178.7
T310252.0
T47538.3
TNM - NN02211.2
N111659.2
N25126.0
N373.6
TNM - MM0196100.0
Histological typeInvasive no special type (NST)16986.2
Others2713.8
Nottingham histological gradeI168.2
II8442.9
III9649.0
Tubule formation>  75%42.0
10–75%168.2
<  10%17689.8
Mitotic rate17638.8
25930.1
36131.1
Nuclear gradeG1126.1
G25025.5
G313468.4
NecrosisAbsent12161.7
Present7538.3
Lymphatic invasionAbsent15680.4
Present3819.6
Inflammatory infiltrateAbsent4422.4
Present15277.6
Ki67<  14%2512.8
≥ 14%17187.2
Estrogen receptorNegative6432.7
Positive13267.3
Progesterone receptorNegative8543.4
Positive11156.6
HER2 overexpressionNegative12965.8
Positive6734.2
SubtypeLuminal A2211.2
Luminal B/HER2 -7739.3
Luminal B/HER2 +4623.5
HER22010.2
Triple-negative3115.8
  1. (a) Excepted at Lymphatic invasion, where n = 194